|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | |
| A61K 31/557 | |||
| A61P 27/06 | |||
| A61K 9/00 | |||
| A61K 9/16 | |||
| A61K 9/70 |
| (11) | Patento numeris | 2411013 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10723400.7 |
| Europos patento paraiškos padavimo data | 2010-03-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/028584 |
| Data | 2010-03-25 |
| (87) | Numeris | WO 2010/111449 |
| Data | 2010-09-30 |
| (30) | Numeris | Data | Šalis |
| 41125009 | 2009-03-25 | US |
| (72) |
ROBINSON, Michael R., US
BURKE, James A., US
LIU, Hui, US
ORILLA, Werhner C., US
SPADA, Lon T., US
WHITCUP, Scott, US
GHEBREMESKEL, Alazar N., US
HUGHES, Patrick M., US
XU, Kun, US
DO, Marianne M., US
|
| (73) |
ALLERGAN, INC.,
2525 Dupont Drive, Irvine, CA 92612,
US
|
| (54) | INTRACAMERAL SUSTAINED RELEASE DRUG DELIVERY SYSTEMS |
| INTRACAMERAL SUSTAINED RELEASE DRUG DELIVERY SYSTEMS |